Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 3 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)
Chen Li,Yantao Tian, Yanan Zheng, Fei Yuan, Zheng Shi,Lin Yang,Hao Chen, Lixin Jiang,Xixun Wang, Ping Zhao,Benyan Zhang,Zhenqiang Wang, Qun Zhao, Jianhong Dong,Changhong Lian,Sanrong Xu, Aimin Zhang, Zhichao Zheng, Kang Wang,Chengxue Dang,Dan Wu,Jian Chen,Yingwei Xue, Bo Liang,Xiangdong Cheng, Qian Wang,Luchuan Chen, Tao Xia, Heli Liu,Dazhi Xu,Jing Zhuang,Tao Wu, Xi Zhao, Wei Wu,Hongzhi Wang,Junsheng Peng,Zhiguo Hou,Rongrong Zheng, Yuting Chen, Kai Yin,Zhenggang Zhu
Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.JCO2400795-JCO2400795, (2024)
Cited0Views0WOSBibtex
0
0
Author Statistics

#Papers: 3

#Citation: 0

H-Index: 0

G-Index: 0

Sociability: 3

Diversity: 0

Activity: 0

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn